Navigation Links
Researchers will test suicide prevention program in high schools
Date:9/7/2010

With students returning to classes, University of Rochester Medical Center researchers are beginning a large, long-term study of the effectiveness of a unique suicide prevention program in high schools across New York and North Dakota.

The study of the program called Sources of Strength, led by Peter Wyman, Ph.D., associate professor of Psychiatry at the Medical Center, is supported by a five-year, $3-million grant awarded by the National Institute of Mental Health.

"Most school-based programs are oriented by a medical model designed to identify students who already are suicidal or highly distresses and refer them to treatment," Wyman said. "That approach has several limitations. The traditional approach assumes that mental health services are available and acceptable to most teens, which is frequently not the case. The tradition model does not change school culture and teen socialization in ways that prevent new instances of suicidal problems."

Sources of Strength aims to "strengthen how teens handle depression, stress and other problems by training influential teen 'peer leaders' who work to change coping practices in their friendship networks," he said.

Wyman's study will include 36 high schools, two-thirds of which will be in New York State. Schools in Chemung, Franklin, Onondaga, Schuyler, Tioga and Wyoming counties already have agreed to participate. As many as 14,000 students will be involved.

"We're focusing on rural and underserved areas where the traditional suicide prevention models are not a reasonable sole solution," Wyman said.

Suicide accounts for more deaths among those aged 10 to 24 in the United States than do all natural causes combined. Each year, 5 to 8 percent of adolescents attempt suicide. Up to one-third of these attempts result in an injury requiring medical intervention.

"This study is a real opportunity to determine how influential peer leaders in high school can change t
'/>"/>

Contact: Michael Wentzel
Michael_Wentzel@urmc.rochester.edu
585-275-1309
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 29, 2015 , ... One may not expect to encounter a kickball game ... exactly what was happening on the campus of Piedmont Crossing , a local ... Kids Only , a five-star childcare center which operates on the same campus. ...
(Date:7/29/2015)... Orange County, CA (PRWEB) , ... July 29, 2015 , ... ... xylitol-based mouthwashes in a variety of gourmet flavors. , Nature’s Artisan was founded by ... in the Post-Baccalaureate program at the UCLA School of Dentistry. Tina was amazed when ...
(Date:7/28/2015)... ... ... Talking About Your Product Pipeline:, How FDA and SEC Regulate Life Sciences ... http://www.fdanews.com/productpipeline , When a company has a product in development, whether drug, device ... regulated by the FDA. , At the same time, the SEC requires that information ...
(Date:7/28/2015)... ... ... City Sports, a specialty sports retailer and a premiere destination for dedicated athletes ... Hanaka, who has served on the Board of Directors for City Sports since 2008 ... has had previous tenures as Chairman and CEO of Golfsmith International Holdings, Inc., Chairman ...
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or ... This would allow insurers to access the on-board vehicle data and better understand customer ... it comes to sharing vehicle data. However times are changing and automakers realize that ...
Breaking Medicine News(10 mins):Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:City Sports Names Marty Hanaka CEO 2Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3
... , THURSDAY, Aug. 4 (HealthDay News) -- A growing number ... the clot-busting drug tissue plasminogen activator (tPA) to treat stroke ... An ischemic stroke is caused by blocked blood flow to ... residents who say they,re comfortable using tPA rose from 73 ...
... for most people means time spent outdoors, which could ... diseases, such as "rickettsial diseases" infectious diseases spread ... ticks and mites. Now a $1.6 million grant ... an entomologist at the University of California, Riverside to ...
... of Cardiology has issued the following statement today: ... the early termination of the PALLAS trial (a randomised ... atrial fibrillation and cardiovascular risk) because of adverse outcomes ... the Management of Atrial Fibrillation (AF) recommend the use ...
... doubles healthcare costs associated with the disease and threatens ... according to researchers at National Jewish Health. The research ... Archives of Allergy, Asthma & Immunology that children with ... days of school each year, compared to 2 or ...
... -- Women with the eating disorders anorexia and bulimia may ... a new study has found. U.K. researchers asked 11,088 ... of gestation. Of those women, 171 (1.5 percent) had anorexia ... bulimia, and another 82 (0.7 percent) had experienced both conditions. ...
... Warburton and Dr Gareth Barker in the University,s School of Physiology ... has investigated why we can recognise faces much better if we ... them in the first place. The study found that when ... face, occurred in a particular place, or at a particular time, ...
Cached Medicine News:Health News:More Neurology Residents Using Clot-Busting Drug for Stroke 2Health News:UC Riverside entomologist to study diseases transmitted by ticks 2Health News:UC Riverside entomologist to study diseases transmitted by ticks 3Health News:ESC announces review of Atrial Fibrillation Guidelines 2Health News:Poorly controlled asthma costly 2Health News:Eating Disorders Can Harm Women's Fertility 2Health News:Have we met before? Scientists show why the brain has the answer 2
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
(Date:7/28/2015)... Ala. , July 28, 2015   Vincari ... for surgeons , has just hired John O,Neil ... Business Development. John has over 30 years of diverse ... roles. Mr. O,Neil,s executive healthcare experience coupled with Vincari,s ... active surgeon allows Vincari to address the challenges both ...
(Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3
... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
Ideal for abdominal, hip, thigh and knee procedures....
Body Suit w/Bra above knee...
Gynecomastia Vest...
Male Compression Vest, Front Closure...
Medicine Products: